Interleukin-10 promoter polymorphisms in myasthenia gravis

Journal of Neuroimmunology

Volumn 210, Issue 1-2, 2009, Pages 63-66

  Alseth, Espen Homleid ^a   Nakkestad, Hanne Linda ^a   Aarseth, Jan ^a   Gilhus, Nils Erik ^a,b   Skeie, Geir Olve ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genetics; IL 10 promoter polymorphism; Myasthenia gravis

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 10;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THYMOMA;

AUTOANTIBODIES; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MUSCLE PROTEINS; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC; PROTEIN KINASES; THYMOMA;

EID: 67349177784     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.02.009     Document Type: Article

References (45)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 6603 (1996) 787-793
2. Bergoffen J., Zmijewski C.M., and Fischbeck K.H. Familial autoimmune myasthenia gravis. Neurology 44 3 Pt 1 (1994) 551-554
3. Castro-Santos P., Suarez A., Lopez-Rivas L., Mozo L., and Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of - 1082 AA low producer IL-10 genotype with steroid dependency. Am. J. Gastroenterol. 101 5 (2006) 1039-1047
4. Conti-Fine B.M., Milani M., and Wang W. CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann. N. Y. Acad. Sci. 1132 (2008) 193-209
5. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., and Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 42 6 (1999) 1101-1108
6. Cush J.J., Splawski J.B., Thomas R., McFarlin J.E., Schulze-Koops H., Davis L.S., Fujita K., and Lipsky P.E. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38 1 (1995) 96-104
7. Degli-Esposti M.A., Andreas A., Christiansen F.T., Schalke B., Albert E., and Dawkins R.L. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 35 6 (1992) 355-364
8. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., and Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. U. S. A. 95 16 (1998) 9465-9470
9. Eskdale J., Keijsers V., Huizinga T., and Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1 2 (1999) 151-155
10. Eskdale J., Kube D., Tesch H., and Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46 2 (1997) 120-128
11. Gautel M., Lakey A., Barlow D.P., Holmes Z., Scales S., Leonard K., Labeit S., Mygland A., Gilhus N.E., and Aarli J.A. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43 8 (1993) 1581-1585
12. Gayo A., Mozo L., Suarez A., Tunon A., Lahoz C., and Gutierrez C. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J. Neuroimmunol. 85 2 (1998) 122-130
13. Gilhus N.E., Pandey J.P., Gaarder P.I., and Aarli J.A. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. J. Autoimmun. 3 3 (1990) 299-305
14. Huang D.R., Zhou Y.H., Xia S.Q., Liu L., Pirskanen R., and Lefvert A.K. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease. J. Neuroimmunol. 94 1-2 (1999) 82-87
15. Huang W.X., Huang P., Fredrikson S., Pirskanen R., and Hillert J. Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis. Eur. J. Neurol. 7 2 (2000) 195-202
16. Hughes B.W., Moro De Casillas M.L., and Kaminski H.J. Pathophysiology of myasthenia gravis. Semin. Neurol. 24 1 (2004) 21-30
17. Itoh K., and Hirohata S. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154 9 (1995) 4341-4350
18. Jelinek D.F., and Lipsky P.E. Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv. Immunol. 40 (1987) 1-59
19. Kube D., Platzer C., von Knethen A., Straub H., Bohlen H., Hafner M., and Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7 1 (1995) 1-7
20. Lefvert A.K., Bergstrom K., Matell G., Osterman P.O., and Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiatry 41 5 (1978) 394-403
21. Lipsky P.E., Hirohata S., Jelinek D.F., McAnally L., and Splawski J.B. Regulation of human B lymphocyte responsiveness. Scand. J. Rheumatol. Suppl. 76 (1988) 229-235
22. Liu Y., Wei S.H., Ho A.S., de Waal Malefyt R., and Moore K.W. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152 4 (1994) 1821-1829
23. Marshall B., Leelayuwat C., Abraham L.J., Pinelli M., and Dawkins R.L. Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease. Immunogenetics 39 1 (1994) 15-20
24. Milani M., Ostlie N., Wang W., and Conti-Fine B.M. T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann. N. Y. Acad. Sci. 998 (2003) 284-307
25. Moore K.W., de Waal Malefyt R., Coffman R.L., O, and Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
26. Mozo L., Suarez A., and Gutierrez C. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin. Exp. Allergy 34 3 (2004) 406-412
27. Murphy J., and Murphy S.F. Myasthenia gravis in identical twins. Neurology 36 1 (1986) 78-80
28. O Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 3 (1998) 275-283
29. Raknes G., Skeie G.O., Gilhus N.E., Aadland S., and Vedeler C. FcgammaRIIA and FcgammaRIIIB polymorphisms in myasthenia gravis. J. Neuroimmunol. 81 1-2 (1998) 173-176
30. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 18 6 (1997) 263-266
31. Romi F., Skeie G.O., Aarli J.A., and Gilhus N.E. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch. Neurol. 57 11 (2000) 1596-1600
32. Skeie G.O., Aarli J.A., and Gilhus N.E. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta. Neurol. Scand. Suppl. 183 (2006) 19-23
33. Skeie G.O., Pandey J.P., Aarli J.A., and Gilhus N.E. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity 26 2 (1997) 111-116
34. Skeie G.O., Pandey J.P., Aarli J.A., and Gilhus N.E. TNFA and TNFB polymorphisms in myasthenia gravis. Arch. Neurol. 56 4 (1999) 457-461
35. Somnier F.E. Myasthenia gravis. Dan. Med. Bull. 43 1 (1996) 1-10
36. Spies T., Morton C.C., Nedospasov S.A., Fiers W., Pious D., and Strominger J.L. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc. Natl. Acad. Sci. U. S. A. 83 22 (1986) 8699-8702
37. Tan J.C., Indelicato S.R., Narula S.K., Zavodny P.J., and Chou C.C. Characterization of interleukin-10 receptors on human and mouse cells. J. Biol. Chem. 268 28 (1993) 21053-21059
38. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24 1 (1997) 1-8
39. Vandiedonck C., Beaurain G., Giraud M., Hue-Beauvais C., Eymard B., Tranchant C., Gajdos P., Dausset J., and Garchon H.J. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 101 43 (2004) 15464-15469
40. Vincent A., and Drachman D.B. Myasthenia gravis. Adv. Neurol. 88 (2002) 159-188
41. Wogensen L., Huang X., and Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 178 1 (1993) 175-185
42. Wogensen L., Lee M.S., and Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 179 4 (1994) 1379-1384
43. Yamamoto A.M., Gajdos P., Eymard B., Tranchant C., Warter J.M., Gomez L., Bourquin C., Bach J.F., and Garchon H.J. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch. Neurol. 58 6 (2001) 885-890
44. Yoshikawa H., Satoh K., Yasukawa Y., and Yamada M. Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis. J. Clin. Neurosci. 9 2 (2002) 133-136
45. Zhang G.X., Xiao B.G., Yu L.Y., van der Meide P.H., and Link H. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. J. Neuroimmunol. 113 1 (2001) 10-18